On Tuesday, Rowan Companies PLC (NYSE:RDC)’s shares declined -1.33% to $16.37.
Rowan Companies plc (RDC) declared that its Board of Directors has declared a quarterly cash dividend of $0.10 per Class A Ordinary Share payable on August 25, 2015 to the shareholders of record at the close of business on August 11, 2015.
Rowan is a global provider of contract drilling services with a fleet of 32 mobile offshore drilling units, composed of 28 jack-up rigs and four ultra-deepwater drillships. The Company’s fleet operates worldwide, counting the United States Gulf of Mexico, the United Kingdom and Norwegian sectors of the North Sea, the Middle East, North Africa, Southeast Asia and Trinidad. The Company’s Class A Ordinary Shares are traded on the New York Stock Exchange under the symbol “RDC.” For more information on the Company, please visit www.rowan.com.
Rowan Companies plc provides offshore oil and gas contract drilling services. It operates a fleet of 30 self-elevating mobile offshore jack-up drilling units, in addition to 3 ultra-deepwater drill ships. The company operates in the United States Gulf of Mexico, the United Kingdom, and Norwegian sectors of the North Sea, the Middle East, West and North Africa, Southeast Asia, and Trinidad. Rowan Companies plc was founded in 1923 and is based in Houston, Texas.
Wendys Co (NASDAQ:WEN)’s shares showed no change to $10.29.
The Wendy’s Company (WEN) declared the declaration of its regular quarterly cash dividend of $0.055 per share, payable on September 15, 2015, to shareholders of record as of September 1, 2015.
The Wendy’s Company, through its auxiliaries, owns and franchises Wendy’s restaurant system. The company is involved in operating, developing, and franchising a system of quick-service restaurants. As of May 26, 2015, its restaurant system comprised of about 6,500 franchised and company-operated restaurants worldwide. The company was formerly known as Wendy’s/Arby’s Group, Inc. and changed its name to The Wendy’s Company in July 2011.
At the end of Tuesday’s trade, Shire PLC (ADR) (NASDAQ:SHPG)‘s shares dipped -5.40% to $253.60.
Shire plc (SHPG) confirms that it made a proposal to Baxalta Incorporated (BXLT) on July 10, 2015, to combine the companies in an all-stock transaction following which Baxalta shareholders would receive, for each Baxalta share, 0.1687 Shire ADRs. The proposal implies a value of $45.23 per Baxalta share and represents a noteworthypremium of 36% over Baxalta’s stock price as of August 3, 2015. Baxalta has declined to engage in substantive talk aboutions regarding the proposal.
The projected combination would generate immediate shareholder value and accelerate the growth plans of both Shire and Baxalta. The combined entity would be the global leader in rare diseases with multiple billion-dollar franchises in high-value therapeutic areas with substantial barriers to entry. Together, Baxalta and Shire are projected to deliver product sales of $20 billion in 2020, advancing the combined pipeline and bringing innovative new therapies to market for patients with rare, often life-threatening, diseases and conditions.
Shire plc, a biopharmaceutical company, together with its auxiliaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various products for the treatment of attention deficit hyperactivity disorder (ADHD), counting VYVANSE/ VENVANSE/ ELVANSE/ TYVENSE/ ELVANS E VUXEN/ADUVANZ; INTUNIV, an alpha-2A receptor agonist; EQUASYM, a methylphenidate hydrochloride; and ADDERALL XR, an extended release treatment for ADHD. The company also provides BUCCOLAM for epilepsy treatment; PENTASA and LIALDA/MEZAVANT for ulcerative colitis treatment; and RESOLOR, a 5-HT4 receptor agonist that is used for the treatment of chronic constipation in women.
Ultra Petroleum Corp. (NYSE:UPL), ended its Tuesday’s trading session with -3.00% loss, and closed at $6.78.
Ultra Petroleum Corp. (UPL) continued to deliver strong financial and operating performance for the second quarter of 2015. Highlights comprise:
- Produced volumes of 70.5 Bcfe of natural gas and oil, an enhance of 20% above year ago levels
- Generated operating cash flow(1)of $121.9 million for the quarter ended June 30, 2015
- Earnings of $32.1 million in the second quarter of 2015, or $0.21 per diluted share – adjusted(2)
- 47 percent cash flow margin(4)for the second quarter of 2015
Second Quarter Results
Ultra Petroleum stated adjusted net income(2) of $32.1 million, or $0.21 per diluted share for the second quarter of 2015. Operating cash flow(1) was $121.9 million for the quarter ended June 30, 2015.
For the second quarter of 2015, production of natural gas and oil was 70.5 billion cubic feet equivalent (Bcfe). The company’s production for the second quarter was comprised of 65.1 billion cubic feet (Bcf) of natural gas and 900.0 thousand barrels (Mbls) of oil and condensate.
During the second quarter of the year, Ultra Petroleum’s average realized natural gas price was $3.33 per thousand cubic feet (Mcf), counting realized gains and losses on commodity hedges. Not taking into account realized gains and losses on commodity derivatives, the company’s average price for natural gas was $2.52 per Mcf. The company’s average realized oil and condensate price was $48.64 per barrel (Bbl).
Second quarter 2015 results comprised of an unrealized, mark-to-market loss of $56.3 million on the company’s commodity hedges. The unrealized loss is typically excluded by the investment community in published estimates.
Ultra Petroleum Corp., an independent oil and gas company, engages in the acquisition, exploration, development, production, and operation of oil and natural gas properties in the United States. It primarily focuses on developing natural gas reserves in the Green River Basin of Wyoming; oil reserves in the Uinta Basin of Utah; and natural gas reserves in the Appalachian Basin of Pennsylvania.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
